Abstract
Design: Data collected from the Women's Interagency HIV Study, a prospective cohort study that enrolled women between October 1994 and November 1995.
Setting: Six clinical consortia based in five cities in the United States (New York, NY; Washington, DC; Los Angeles, CA; San Francisco, CA; and Chicago, IL).
Participants: A total of 1691 HIV seropositive women with a study visit after April 1996.
Main results: Beginning in April 1996, the self reported use of HAART increased over time, with more than 50% of the cohort reporting HAART use in 1999. There was a 23% decline per semester in the incidence of AIDS from April 1996 (95% confidence intervals (CI) -29% to -16%). Furthermore, there was a 21% decline of the semiannual mortality rates among those with AIDS at baseline (95% CI -27% to -14%) and an 11% decline among those AIDS free at baseline (95% CI -3% to -18%). CD4+ lymphocyte counts either increased (women with baseline AIDS) or stabilised (women without baseline AIDS) after April 1996, and HIV RNA levels dramatically declined in both groups, although the percentage of women with HIV RNA above 4000 cps/ml remained stable at approximately 40% since mid-1997.
Conclusions: Despite concerns regarding the use of antiretroviral therapies in this population, the use of therapies led to improved immunological function, suppressed HIV disease activity, and dramatic declines in morbidity and mortality.
Full Text
The Full Text of this article is available as a PDF (157.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahdieh L., Gange S. J., Greenblatt R., Minkoff H., Anastos K., Young M., Nowicki M., Kovacs A., Cohen M., Muñoz A. Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus. Am J Epidemiol. 2000 Nov 15;152(10):923–933. doi: 10.1093/aje/152.10.923. [DOI] [PubMed] [Google Scholar]
- Anastos K., Gange S. J., Lau B., Weiser B., Detels R., Giorgi J. V., Margolick J. B., Cohen M., Phair J., Melnick S. Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):218–226. doi: 10.1097/00126334-200007010-00004. [DOI] [PubMed] [Google Scholar]
- Andersen R., Bozzette S., Shapiro M., St Clair P., Morton S., Crystal S., Goldman D., Wenger N., Gifford A., Leibowitz A. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res. 2000 Jun;35(2):389–416. [PMC free article] [PubMed] [Google Scholar]
- Autran B., Carcelain G., Li T. S., Blanc C., Mathez D., Tubiana R., Katlama C., Debré P., Leibowitch J. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997 Jul 4;277(5322):112–116. doi: 10.1126/science.277.5322.112. [DOI] [PubMed] [Google Scholar]
- Barkan S. E., Melnick S. L., Preston-Martin S., Weber K., Kalish L. A., Miotti P., Young M., Greenblatt R., Sacks H., Feldman J. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998 Mar;9(2):117–125. [PubMed] [Google Scholar]
- Bozzette S. A., Berry S. H., Duan N., Frankel M. R., Leibowitz A. A., Lefkowitz D., Emmons C. A., Senterfitt J. W., Berk M. L., Morton S. C. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998 Dec 24;339(26):1897–1904. doi: 10.1056/NEJM199812243392606. [DOI] [PubMed] [Google Scholar]
- Detels R., Muñoz A., McFarlane G., Kingsley L. A., Margolick J. B., Giorgi J., Schrager L. K., Phair J. P. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA. 1998 Nov 4;280(17):1497–1503. doi: 10.1001/jama.280.17.1497. [DOI] [PubMed] [Google Scholar]
- Egger M., Hirschel B., Francioli P., Sudre P., Wirz M., Flepp M., Rickenbach M., Malinverni R., Vernazza P., Battegay M. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ. 1997 Nov 8;315(7117):1194–1199. doi: 10.1136/bmj.315.7117.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farzadegan H., Hoover D. R., Astemborski J., Lyles C. M., Margolick J. B., Markham R. B., Quinn T. C., Vlahov D. Sex differences in HIV-1 viral load and progression to AIDS. Lancet. 1998 Nov 7;352(9139):1510–1514. doi: 10.1016/S0140-6736(98)02372-1. [DOI] [PubMed] [Google Scholar]
- Glesby M. J., Hoover D. R. Survivor treatment selection bias in observational studies: examples from the AIDS literature. Ann Intern Med. 1996 Jun 1;124(11):999–1005. doi: 10.7326/0003-4819-124-11-199606010-00008. [DOI] [PubMed] [Google Scholar]
- Graham N. M., Zeger S. L., Park L. P., Phair J. P., Detels R., Vermund S. H., Ho M., Saah A. J. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet. 1991 Aug 3;338(8762):265–269. doi: 10.1016/0140-6736(91)90414-k. [DOI] [PubMed] [Google Scholar]
- Greenblatt R. M., Ameli N., Grant R. M., Bacchetti P., Taylor R. N. Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women. J Infect Dis. 2000 Jan;181(1):82–90. doi: 10.1086/315207. [DOI] [PubMed] [Google Scholar]
- Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and the Henry J. Kaiser Family Foundation. Ann Intern Med. 1998 Jun 15;128(12 Pt 2):1079–1100. doi: 10.7326/0003-4819-128-12_part_2-199806151-00003. [DOI] [PubMed] [Google Scholar]
- Gulick R. M., Mellors J. W., Havlir D., Eron J. J., Gonzalez C., McMahon D., Richman D. D., Valentine F. T., Jonas L., Meibohm A. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997 Sep 11;337(11):734–739. doi: 10.1056/NEJM199709113371102. [DOI] [PubMed] [Google Scholar]
- Heckman T. G., Somlai A. M., Peters J., Walker J., Otto-Salaj L., Galdabini C. A., Kelly J. A. Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care. 1998 Jun;10(3):365–375. doi: 10.1080/713612410. [DOI] [PubMed] [Google Scholar]
- Hessol N. A., Anastos K., Levine A. M., Ameli N., Cohen M., Young M., Augenbraun M., Miotti P., Gange S. J. Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study Group. AIDS Res Hum Retroviruses. 2000 Aug 10;16(12):1105–1111. doi: 10.1089/088922200414947. [DOI] [PubMed] [Google Scholar]
- Hessol N. A., Schneider M., Greenblatt R. M., Bacon M., Barranday Y., Holman S., Robison E., Williams C., Cohen M., Weber K. Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy. Am J Epidemiol. 2001 Sep 15;154(6):563–573. doi: 10.1093/aje/154.6.563. [DOI] [PubMed] [Google Scholar]
- Hessol N. A., Schwarcz S., Ameli N., Oliver G., Greenblatt R. M. Accuracy of self-reports of acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related conditions in women. Am J Epidemiol. 2001 Jun 1;153(11):1128–1133. doi: 10.1093/aje/153.11.1128. [DOI] [PubMed] [Google Scholar]
- Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995 Jan 12;373(6510):123–126. doi: 10.1038/373123a0. [DOI] [PubMed] [Google Scholar]
- Hogg R. S., O'Shaughnessy M. V., Gataric N., Yip B., Craib K., Schechter M. T., Montaner J. S. Decline in deaths from AIDS due to new antiretrovirals. Lancet. 1997 May 3;349(9061):1294–1294. doi: 10.1016/S0140-6736(05)62505-6. [DOI] [PubMed] [Google Scholar]
- Hoover D. R., Muñoz A., He Y., Taylor J. M., Kingsley L., Chmiel J. S., Saah A. The effectiveness of interventions on incubation of AIDS as measured by secular increases within a population. Stat Med. 1994 Oct 15;13(19-20):2127–2139. doi: 10.1002/sim.4780131920. [DOI] [PubMed] [Google Scholar]
- Kleeberger C. A., Phair J. P., Strathdee S. A., Detels R., Kingsley L., Jacobson L. P. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):82–92. doi: 10.1097/00126334-200101010-00012. [DOI] [PubMed] [Google Scholar]
- Laird N. M., Ware J. H. Random-effects models for longitudinal data. Biometrics. 1982 Dec;38(4):963–974. [PubMed] [Google Scholar]
- Ledergerber B., Egger M., Opravil M., Telenti A., Hirschel B., Battegay M., Vernazza P., Sudre P., Flepp M., Furrer H. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet. 1999 Mar 13;353(9156):863–868. doi: 10.1016/s0140-6736(99)01122-8. [DOI] [PubMed] [Google Scholar]
- Lee L. M., Karon J. M., Selik R., Neal J. J., Fleming P. L. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. JAMA. 2001 Mar 14;285(10):1308–1315. doi: 10.1001/jama.285.10.1308. [DOI] [PubMed] [Google Scholar]
- Marx R., Hirozawa A., Soskolne V., Liu Y., Katz M. H. Barriers to getting needed services for Ryan White CARE clients. AIDS Care. 2001 Apr;13(2):233–242. doi: 10.1080/09540120020027404. [DOI] [PubMed] [Google Scholar]
- Mocroft A., Vella S., Benfield T. L., Chiesi A., Miller V., Gargalianos P., d'Arminio Monforte A., Yust I., Bruun J. N., Phillips A. N. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998 Nov 28;352(9142):1725–1730. doi: 10.1016/s0140-6736(98)03201-2. [DOI] [PubMed] [Google Scholar]
- Muñoz A., Gange S. J., Jacobson L. P. Distinguishing efficacy, individual effectiveness and population effectiveness of therapies. AIDS. 2000 Apr 14;14(6):754–756. doi: 10.1097/00002030-200004140-00020. [DOI] [PubMed] [Google Scholar]
- Palacio H., Shiboski C. H., Yelin E. H., Hessol N. A., Greenblatt R. M. Access to and utilization of primary care services among HIV-infected women. J Acquir Immune Defic Syndr. 1999 Aug 1;21(4):293–300. doi: 10.1097/00126334-199908010-00006. [DOI] [PubMed] [Google Scholar]
- Palella F. J., Jr, Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–860. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
- Pezzotti P., Napoli P. A., Acciai S., Boros S., Urciuoli R., Lazzeri V., Rezza G. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group. AIDS. 1999 Feb 4;13(2):249–255. doi: 10.1097/00002030-199902040-00013. [DOI] [PubMed] [Google Scholar]
- Phillips A. N., Grabar S., Tassie J. M., Costagliola D., Lundgren J. D., Egger M. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS. 1999 Oct 22;13(15):2075–2082. doi: 10.1097/00002030-199910220-00010. [DOI] [PubMed] [Google Scholar]
- Porta D., Rapiti E., Forastiere F., Pezzotti P., Perucci C. A. Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998. Lazio AIDS Surveillance Collaborative Group. AIDS. 1999 Oct 22;13(15):2125–2131. doi: 10.1097/00002030-199910220-00016. [DOI] [PubMed] [Google Scholar]
- Poundstone K. E., Chaisson R. E., Moore R. D. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS. 2001 Jun 15;15(9):1115–1123. doi: 10.1097/00002030-200106150-00006. [DOI] [PubMed] [Google Scholar]
- Rapiti E., Porta D., Forastiere F., Fusco D., Perucci C. A. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Lazio AIDS Surveillance Collaborative Group. Epidemiology. 2000 Sep;11(5):496–501. doi: 10.1097/00001648-200009000-00003. [DOI] [PubMed] [Google Scholar]
- Robins J. M., Hernán M. A., Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000 Sep;11(5):550–560. doi: 10.1097/00001648-200009000-00011. [DOI] [PubMed] [Google Scholar]
- Rosenberg P. S., Biggar R. J. Trends in HIV incidence among young adults in the United States. JAMA. 1998 Jun 17;279(23):1894–1899. doi: 10.1001/jama.279.23.1894. [DOI] [PubMed] [Google Scholar]
- Rosenberg P. S. Scope of the AIDS epidemic in the United States. Science. 1995 Nov 24;270(5240):1372–1375. doi: 10.1126/science.270.5240.1372. [DOI] [PubMed] [Google Scholar]
- Sabin C. A. Assessing the impact of highly active antiretroviral therapy on AIDS and death. AIDS. 1999 Oct 22;13(15):2165–2166. doi: 10.1097/00002030-199910220-00021. [DOI] [PubMed] [Google Scholar]
- Schapiro J. M., Winters M. A., Stewart F., Efron B., Norris J., Kozal M. J., Merigan T. C. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients. Ann Intern Med. 1996 Jun 15;124(12):1039–1050. doi: 10.7326/0003-4819-124-12-199606150-00003. [DOI] [PubMed] [Google Scholar]
- Shapiro M. F., Morton S. C., McCaffrey D. F., Senterfitt J. W., Fleishman J. A., Perlman J. F., Athey L. A., Keesey J. W., Goldman D. P., Berry S. H. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999 Jun 23;281(24):2305–2315. doi: 10.1001/jama.281.24.2305. [DOI] [PubMed] [Google Scholar]
- Sterling T. R., Vlahov D., Astemborski J., Hoover D. R., Margolick J. B., Quinn T. C. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med. 2001 Mar 8;344(10):720–725. doi: 10.1056/NEJM200103083441003. [DOI] [PubMed] [Google Scholar]
- Tarwater P. M., Mellors J., Gore M. E., Margolick J. B., Phair J., Detels R., Muñoz A. Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts. Am J Epidemiol. 2001 Oct 1;154(7):675–681. doi: 10.1093/aje/154.7.675. [DOI] [PubMed] [Google Scholar]
- Vella S., Giuliano M., Pezzotti P., Agresti M. G., Tomino C., Floridia M., Greco D., Moroni M., Visco G., Milazzo F. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group. JAMA. 1992 Mar 4;267(9):1232–1236. [PubMed] [Google Scholar]
- Veugelers P. J., Cornelisse P. G., Craib K. J., Marion S. A., Hogg R. S., Strathdee S. A., Montaner J. S., O'Shaughnessy M. V., Schechter M. T. Models of survival in HIV infection and their use in the quantification of treatment benefits. Am J Epidemiol. 1998 Sep 1;148(5):487–496. doi: 10.1093/oxfordjournals.aje.a009674. [DOI] [PubMed] [Google Scholar]
- Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995 Jan 12;373(6510):117–122. doi: 10.1038/373117a0. [DOI] [PubMed] [Google Scholar]